References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69(1):7–34. doi:https://doi.org/10.3322/caac.21551
- Li WQ, Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan K-F, Liu W-D, Hu Y, Han Z-X, et al. Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J Natl Cancer Inst. 2014;106(7):dju116. doi:https://doi.org/10.1093/jnci/dju116.
- Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, Holleczek B, Johnston BT, Cook MB, Bannon F, et al. Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: results from EUROCARE-5. Eur J Cancer. 2015;51(15):2144–2157. doi:https://doi.org/10.1016/j.ejca.2015.07.026
- Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904–914. doi:https://doi.org/10.1016/j.molcel.2011.08.018
- Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15(1):7–21. doi:https://doi.org/10.1038/nrg3606
- Ren X, Chen C, Luo Y, Liu M, Li Y, Zheng S, Ye H, Fu Z, Li M, Li Z, et al. lncRNA-PLACT1 sustains activation of NF-κB pathway through a positive feedback loop with IκBα/E2F1 axis in pancreatic cancer. Mol Cancer. 2020;19(1):35. doi:https://doi.org/10.1186/s12943-020-01153-1
- Yu H, Yao X, Meng X. A novel LncRNA (LOC105371049) regulates colorectal cancer proliferation, metastasis and metabolism. Ann Oncol. 2019;30 (Suppl 4):iv35–iv36. doi:https://doi.org/10.1093/annonc/mdz155.131
- Ba M-C, Ba Z, Long H, Cui S-Z, Gong Y-F, Yan Z-F, Lin K-P, Wu Y-B, Tu Y-N. LncRNA AC093818.1 accelerates gastric cancer metastasis by epigenetically promoting PDK1 expression. Cell Death Dis. 2020;11(1):64. doi:https://doi.org/10.1038/s41419-020-2245-2
- Wang C-J, Zhu C-C, Xu J, Wang M, Zhao W-Y, Liu Q, Zhao G, Zhang Z-Z. The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs. Mol Cancer. 2019;18(1):115. doi:https://doi.org/10.1186/s12943-019-1032-0
- Martino OD, Welch JS. Retinoic acid receptors in acute myeloid leukemia therapy. Cancers (Basel). 2019;11(12):1915. doi:https://doi.org/10.3390/cancers11121915
- Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988;72(2):567–572.
- Viswanathan S, Berlin Grace VM, Danisha JP. Enhancement of tumor suppressor RAR-β protein expression by cationic liposomal-ATRA treatment in benzo(a)pyrene-induced lung cancer mice model. Naunyn Schmiedebergs Arch Pharmacol. 2019;392(4):415–426. doi:https://doi.org/10.1007/s00210-018-01598-8
- Huang S, Chen Y, Liang Z-M, Li N-N, Liu Y, Zhu Y, Liao D, Zhou XZ, Lu KP, Yao Y, et al. Targeting pin1 by all-trans retinoic acid (ATRA) overcomes tamoxifen resistance in breast cancer via multifactorial mechanisms. Front Cell Dev Biol. 2019;7:322. doi:https://doi.org/10.3389/fcell.2019.00322
- Liu W, Song Y, Zhang C, Gao P, Huang B, Yang J. The protective role of all-transretinoic acid (ATRA) against colorectal cancer development is achieved via increasing miR-3666 expression and decreasing E2F7 expression. Biomed Pharmacother. 2018;104:94–101. doi:https://doi.org/10.1016/j.biopha.2018.05.015
- Nguyen PH, Giraud J, Staedel C, Chambonnier L, Dubus P, Chevret E, Boeuf H, Gauthereau X, Rousseau B, Fevre M, et al. All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth. Oncogene. 2016;35(43):5619–5628. doi:https://doi.org/10.1038/onc.2016.87
- Bouriez D, Giraud J, Gronnier C, Varon C. Efficiency of all-trans retinoic acid on gastric cancer: a narrative literature review. Int J Mol Sci. 2018;19(11):3388. doi:https://doi.org/10.3390/ijms19113388
- Niederreither K, Dolle P. Retinoic acid in development: towards an integrated view. Nat Rev Genet. 2008;9(7):541–553. doi:https://doi.org/10.1038/nrg2340
- Duester G. Retinoic acid synthesis and signaling during early organogenesis. Cell. 2008;134(6):921–931. doi:https://doi.org/10.1016/j.cell.2008.09.002
- Theodosiou M, Laudet V, Schubert M. From carrot to clinic: an overview of the retinoic acid signaling pathway. Cell Mol Life Sci. 2010;67(9):1423–1445. doi:https://doi.org/10.1007/s00018-010-0268-z
- Mao Y, Liu R, Zhou H, Yin S, Zhao Q, Ding X, Wang H. Transcriptome analysis of miRNA-lncRNA-mRNA interactions in the malignant transformation process of gastric cancer initiation. Cancer Gene Ther. 2017;24(6):267–275. doi:https://doi.org/10.1038/cgt.2017.14
- Gao L, He Y, Wang K, Wang C, Wu H, Hu A, Ruan L, Bo Q, Chen W, Hu C, et al. All-trans retinoic acid suppressed GES-1 cell proliferation induced by exosomes from patients with precancerous lesions by arresting the cell cycle in S-phase. Eur J Cancer Prev. 2020. doi:https://doi.org/10.1097/CEJ.0000000000000571
- Kanda M, Ikeda T, Fujiwara S. Identification of a retinoic acid-responsive neural enhancer in the Ciona intestinalis Hox1 gene. Dev Growth Differ. 2013;55(2):260–269. doi:https://doi.org/10.1111/dgd.12033
- Haenszel W, Correa P, López A, Cuello C, Zarama G, Zavala D, Fontham E. Serum micronutrient levels in relation to gastric pathology. Int J Cancer. 1985;36(1):43–48. doi:https://doi.org/10.1002/ijc.2910360108
- Li T, Zhang Y, Meng YP, Bo LS, Ke WB. miR-542-3p appended sorafenib/all-trans retinoic acid (ATRA)-loaded lipid nanoparticles to enhance the anticancer efficacy in gastric cancers. Pharm Res. 2017;34(12):2710–2719. doi:https://doi.org/10.1007/s11095-017-2202-7
- Lin J, Zhu Q, Huang J, Cai R, Kuang Y. Hypoxia promotes vascular smooth muscle cell (VSMC) differentiation of adipose-derived stem cell (ADSC) by regulating Mettl3 and paracrine factors. Stem Cells Int. 2020;2020:2830565. doi:https://doi.org/10.1155/2020/2830565
- Le Bras A. The lncRNA CHROME regulates cholesterol homeostasis. Nat Rev Cardiol. 2019;16(2):71. doi:https://doi.org/10.1038/s41569-018-0154-1
- Zhang Y, Liu C, Barbier O, Smalling R, Tsuchiya H, Lee S, Delker D, Zou A, Hagedorn CH, Wang L, et al. Bcl2 is a critical regulator of bile acid homeostasis by dictating Shp and lncRNA H19 function. Sci Rep. 2016;6:20559. doi:https://doi.org/10.1038/srep20559
- Ang CE, Ma Q, Wapinski OL, Fan SH, Flynn RA, Lee QY, Coe B, Onoguchi M, Olmos VH, Do BT, et al. The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders. Elife. 2019;8:e41770. doi:https://doi.org/10.7554/eLife.41770
- Jiang M, Zhang S, Yang Z, Lin H, Zhu J, Liu L, Wang W, Liu S, Liu W, Ma Y, et al. Self-recognition of an inducible host lncRNA by RIG-I feedback restricts innate immune response. Cell. 2018;173(4):906–919 e13. doi:https://doi.org/10.1016/j.cell.2018.03.064
- Liu HT, Liu S, Liu L, Ma RR, Gao P. EGR1-mediated transcription of lncRNA-HNF1A-AS1 promotes cell-cycle progression in gastric cancer. Cancer Res. 2018;78(20):5877–5890. doi:https://doi.org/10.1158/0008-5472.CAN-18-1011
- Hua JT, Ahmed M, Guo H, Zhang Y, Chen S, Soares F, Lu J, Zhou S, Wang M, Li H, et al. Risk SNP-mediated promoter-enhancer switching drives prostate cancer through lncRNA PCAT19. Cell. 2018;174(3):564–575 e18. doi:https://doi.org/10.1016/j.cell.2018.06.014
- Noh JH, Gorospe M. AKTions by cytoplasmic lncRNA CASC9 promote hepatocellular carcinoma survival. Hepatology. 2018;68(5):1675–1677. doi:https://doi.org/10.1002/hep.30165
- Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411(6835):342–348. doi:https://doi.org/10.1038/35077213
- Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127(4):679–695. doi:https://doi.org/10.1016/j.cell.2006.11.001
- Gao Q, Zhao Y-J, Wang X-Y, Guo W-J, Gao S, Wei L, Shi J-Y, Shi G-M, Wang Z-C, Zhang Y-N, et al. Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients. Gastroenterology. 2014;146(5):1397–1407. doi:https://doi.org/10.1053/j.gastro.2014.01.062
- Wang H, Lu B, Ren S, Wu F, Wang X, Yan C, Wang Z. Long noncoding RNA LINC01116 contributes to gefitinib resistance in non-small cell lung cancer through regulating IFI44. Mol Ther Nucleic Acids. 2020;19:218–227. doi:https://doi.org/10.1016/j.omtn.2019.10.039
- Engreitz JM, Ollikainen N, Guttman M. Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression. Nat Rev Mol Cell Biol. 2016;17(12):756–770. doi:https://doi.org/10.1038/nrm.2016.126
- Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81:145–166. doi:https://doi.org/10.1146/annurev-biochem-051410-092902
- Bierhoff H, Postepska-Igielska A, Grummt I. Noisy silence: non-coding RNA and heterochromatin formation at repetitive elements. Epigenetics. 2014;9(1):53–61. doi:https://doi.org/10.4161/epi.26485
- Marchese FP, Huarte M. Long non-coding RNAs and chromatin modifiers: their place in the epigenetic code. Epigenetics. 2014;9(1):21–26. doi:https://doi.org/10.4161/epi.27472
- Yoon JH, Abdelmohsen K, Gorospe M. Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol. 2013;425(19):3723–3730. doi:https://doi.org/10.1016/j.jmb.2012.11.024
- Janesick A, Nguyen TTL, Aisaki K-i, Igarashi K, Kitajima S, Chandraratna RAS, Kanno J, Blumberg B. Active repression by RARγ signaling is required for vertebrate axial elongation. Development. 2014;141(11):2260–2270. doi:https://doi.org/10.1242/dev.103705
- Weston AD, Blumberg B, Underhill TM. Active repression by unliganded retinoid receptors in development: less is sometimes more. J Cell Biol. 2003;161(2):223–228. doi:https://doi.org/10.1083/jcb.200211117
- Kumar S, Duester G. Retinoic acid controls body axis extension by directly repressing Fgf8 transcription. Development. 2014;141(15):2972–2977. doi:https://doi.org/10.1242/dev.112367
- Studer M, Popperl H, Marshall H, Kuroiwa A, Krumlauf R. Role of a conserved retinoic acid response element in rhombomere restriction of Hoxb-1. Science. 1994;265(5179):1728–1732. doi:https://doi.org/10.1126/science.7916164